Ritonavir-boosted tipranavir demonstrates superior efficacy to ritonavir-boosted protease inhibitors in treatment-experienced HIV-infected patients: 24-Week results of the RESIST-2 trial

  1. Cahn, P.
  2. Villacian, J.
  3. Lazzarin, A.
  4. Katlama, C.
  5. Grinsztejn, B.
  6. Arasteh, K.
  7. López, P.
  8. Clumeck, N.
  9. Gerstoft, J.
  10. Stavrianeas, N.
  11. Moreno, S.
  12. Antunes, F.
  13. Neubacher, D.
  14. Mayers, D.
Revue:
Clinical Infectious Diseases

ISSN: 1058-4838

Année de publication: 2006

Volumen: 43

Número: 10

Pages: 1347-1356

Type: Article

DOI: 10.1086/508352 GOOGLE SCHOLAR lock_openAccès ouvert editor

Objectifs de Développement Durable

La source de données: Scopus